logo
Humans may have untapped 'superpowers' from genes related to hibernation, scientists claim

Humans may have untapped 'superpowers' from genes related to hibernation, scientists claim

Yahoo7 hours ago
When you buy through links on our articles, Future and its syndication partners may earn a commission.
Hibernating mammals rely on particular genes to adjust their metabolisms as they enter that unique, low-energy state — and humans actually carry that same hibernation-related DNA.
Now, early research hints that leveraging this particular DNA could help treat medical conditions in people, scientists say.
Hibernation offers "a whole bunch of different biometrically important superpowers," senior study author Christopher Gregg, a human genetics professor at the University of Utah, told Live Science.
For example, ground squirrels can develop reversible insulin resistance that helps them rapidly gain weight before they hibernate but starts fading as hibernation gets underway. A better understanding of how hibernators flip this switch could be useful for tackling the insulin resistance that characterizes type 2 diabetes, Gregg suggested.
Hibernating animals also protect their nervous systems from damage that could be caused by sudden changes in blood flow. "When they come out of hibernation, their brain is reperfused with blood," Gregg said. "Often that would cause a lot of damage, like a stroke, but they've developed ways to prevent that damage from happening."
Gregg and his colleagues think tapping into hibernation-related genes in people could unlock similar benefits.
Related: Best-ever map of the human genome sheds light on 'jumping genes,' 'junk DNA' and more
A 'hub' of hibernation genes
In a pair of studies published Thursday (July 31) in the journal Science, Gregg and his team pinpointed key levers that control genes related to hibernation, showing how they differ between animals that hibernate and those that don't. Then, in the lab experiments, they delved into the effects of deleting these levers in lab mice.
Although mice don't hibernate, they can enter torpor — a lethargic state of decreased metabolism, movement and body temperature that typically lasts for less than a day — after fasting for at least six hours. This made mice a suitable genetic model for studying these effects.
Using the gene-editing technique CRISPR, the scientists engineered mice with one of five conserved noncoding cis elements (CREs) deactivated, or "knocked out." These CREs act as levers to control genes that, in turn, code for proteins that carry out biological functions.
The CREs targeted in the study lie near a gene cluster called the "fat mass and obesity-related locus," or the FTO locus, which is also found in humans. Gene variants found within the cluster have been tied to an elevated risk of obesity and related conditions. Broadly speaking, the FTO locus is known to be important for controlling metabolism, energy expenditure and body mass.
By knocking out the CREs, the researchers were able to change the mice's weights, metabolic rates and foraging behaviors. Some deletions sped up or slowed down weight gain, others turned metabolic rate up or down, and some affected how quickly the mice's body temperatures recovered after torpor, the researchers said in a statement.
This finding is "highly promising," particularly given the FTO locus plays a well-known role in human obesity, Kelly Drew, a specialist on hibernation biology at the University of Alaska Fairbanks, told Live Science in an email.
Knocking out one CRE — called E1 — in female mice caused them to gain more weight on a high-fat diet than did a comparison group with all of their DNA intact. Deleting a different CRE, called E3, changed the foraging behavior of both male and female mice, specifically changing how they searched for food hidden in an arena.
"This suggests that important differences in foraging and decision processes may exist between hibernators and non-hibernators and the elements we uncovered might be involved," Gregg said.
Unknowns to address
The study authors said their results could be relevant to humans, since the underlying genes don't differ much between mammals. "It's how [the mammals] turn those genes on and off at different times and then for different durations and in different combinations that shape different species," Gregg said.
However, "it's definitely not as simple as introducing the same changes in human DNA," Joanna Kelley, a professor who specialises in functional genomics at the University of California, Santa Cruz, told Live Science in an email. "Humans are not capable of fasting-induced torpor, which is the reason why mice are used in these studies," said Kelley, who was not involved in the work.
She suggested that future work include animals incapable of torpor, and focus on unpacking all the downstream effects of the deleted CREs. As is, the current study "definitely points the field in a new direction" in terms of how scientists understand the genetic controls driving changes in hibernators throughout the year, she added.
Drew also highlighted that torpor in mice is triggered by fasting, while true hibernation is triggered by hormonal and seasonal changes and internal clocks. So while the CREs and genes the study identified are likely critical parts of a metabolic "toolkit" that responds to fasting, they may not be a "master switch" that turns hibernation on or off.
RELATED STORIES
—Scientists may be able to put Mars-bound astronauts into 'suspended animation' using sound waves, mouse study suggests
—'Let's just study males and keep it simple': How excluding female animals from research held neuroscience back, and could do so again
—Weight loss may 'rejuvenate' fat tissue in the body
"Nevertheless, uncovering these fundamental mechanisms in a tractable model like the mouse is an invaluable stepping stone for future research," Drew said.
Gregg emphasized that much remains unknown, including why the effects of some deletions differed in female mice versus male mice or how the changes in foraging behavior seen in mice might manifest in humans. The team also plans to research what would happen if they deleted more than one hibernation-linked CRE at a time in mice.
Down the line, Gregg thinks it could be possible to tweak the activity of humans' "hibernation hub genes" with drugs. The idea would be that this approach could yield the benefits of that gene activity — like neuroprotection — without patients having to actually hibernate, he said.
Solve the daily Crossword
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Utah Fertility Center, an Ivy Fertility Center, Hires Dr. Addison W. Alley
Utah Fertility Center, an Ivy Fertility Center, Hires Dr. Addison W. Alley

Yahoo

time19 minutes ago

  • Yahoo

Utah Fertility Center, an Ivy Fertility Center, Hires Dr. Addison W. Alley

SAN DIEGO, August 05, 2025--(BUSINESS WIRE)--Ivy Fertility, a collaborative network of globally-renowned fertility clinics, is proud to welcome Addison W. Alley, MD, to its team of physicians at Utah Fertility Center. Dr. Alley is a board-certified obstetrician-gynecologist and fellowship-trained reproductive endocrinologist and infertility specialist. He will begin seeing new patients at UFC's Pleasant Grove and Midvale locations in September 2025. "We are thrilled to welcome Dr. Alley to our team," said Deirdre Conway, MD, Practice Director at Utah Fertility Center. "His strong academic background, innovative research, and clear dedication to compassionate care make him an outstanding addition to our clinic. Patients will benefit greatly from his thoughtful and thorough approach." Dr. Alley brings extensive clinical experience and research insight to the Ivy network. He earned his medical degree from the George Washington University School of Medicine and Health Sciences and completed his residency in Obstetrics and Gynecology at the University of Arizona College of Medicine Phoenix, where he was selected as First Administrative Chief Resident. Dr. Alley then pursued a fellowship in Reproductive Endocrinology and Infertility at the University of Utah School of Medicine, where he also completed a Master of Science in Clinical Investigation. Throughout his training and career, Dr. Alley has remained deeply engaged in advancing reproductive medicine through research. He is the primary author of multiple peer-reviewed publications and conference presentations, including work on oncofertility, genetics, fertility preservation, maternal wellness and improving pregnancy outcomes. His research has been featured at prestigious conferences including ASRM, ESHRE, and SRI. "I'm honored to join the exceptional team at Utah Fertility Center," said Dr. Alley. "It's a privilege to support patients during one of the most meaningful times of their lives. I look forward to delivering personalized care while working alongside a group of clinicians who share my commitment to innovation, inclusion, and compassion." About Ivy Fertility Ivy Fertility is globally recognized as pioneers and innovators in the field of advanced reproductive technologies, in-vitro fertilization, third-party reproduction, andrology, and fertility research. The Ivy Fertility network includes Dallas IVF, Fertility Associates of Memphis, Fertility Centers of Orange County, Idaho Fertility Center, IVF Fertility Center, Los Angeles Reproductive Center, Nevada Center for Reproductive Medicine, Nevada Fertility Center, Northern California Fertility Medical Center, NOVA IVF, Pacific Northwest Fertility, Reproductive Partners Medical Group, San Diego Fertility Center, Utah Fertility Center, and Virginia Fertility & IVF. By developing new procedures, achieving scientific breakthroughs, and teaching the latest techniques, Ivy Fertility upholds its commitment to successful outcomes and continually contributes to the development of the entire fertility community. The Ivy team is passionate about its family-building mission and works tirelessly each day to help patients become parents. View source version on Contacts Constance Rapson, constance@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Linda Yaccarino joins health tech platform eMed as CEO after leaving X
Linda Yaccarino joins health tech platform eMed as CEO after leaving X

TechCrunch

time20 minutes ago

  • TechCrunch

Linda Yaccarino joins health tech platform eMed as CEO after leaving X

Linda Yaccarino's next role after departing X as CEO will be another chief executive role at eMed Population Health, an AI startup building a tech platform for patients using GLP-1s. Yaccarino was a longtime advertising executive at NBCUniversal, but left to join X as CEO for two years, where she managed to have a positive impact on the social network's troubled ad revenue model, despite her and Elon Musk's shared approach to minimizing content moderation. Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her 'undeniable ability to negotiate new partnerships' — it certainly also helps that her tenure at X made her well-known in the tech world, drawing more eyes toward the startup. eMed previously produced a tech platform that was designed to be used with at-home COVID-19 rapid antigen tests, guiding users through the process of administering these tests properly. Now, eMed is focused on GLP-1s, the class of drugs like Ozempic, which can be used for both weight management and treatment of type II diabetes. 'To be a leader in today's healthcare marketplace, companies need to have a fearless tenacity that allows them to not only grow, but to also be brave enough to step forward and redefine an entire industry,' Yaccarino said in a press release. 'We are very well-positioned to be that tenacious leader, striving toward our ultimate goal of improving global healthcare outcomes through our groundbreaking services and platforms.'

NASA and Congress Wrestle Over the Space Station—and How to Replace It
NASA and Congress Wrestle Over the Space Station—and How to Replace It

Wall Street Journal

time22 minutes ago

  • Wall Street Journal

NASA and Congress Wrestle Over the Space Station—and How to Replace It

The fight over government spending is reaching 250 miles above the Earth's surface. The International Space Station for more than two decades has been the centerpiece of human spaceflight at the National Aeronautics and Space Administration. Government leaders are now jousting over funding for the ISS, while NASA is signaling it will start pulling back on some station activities ahead of its planned decommissioning in 2030, when private space stations are envisioned taking its place.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store